# FDA Inspection 989405 - Cardinal Health dba Specialty Pharmaceutical Services - October 05, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/cardinal-health-dba-specialty-pharmaceutical-services/ba7d8818-3fbe-4e4a-bd05-1a6b2b29db42
Source feed: FDA_Inspections

> FDA Inspection 989405 for Cardinal Health dba Specialty Pharmaceutical Services on October 05, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 989405
- Company Name: Cardinal Health dba Specialty Pharmaceutical Services
- Inspection Date: 2016-10-05
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1053669 - 2018-04-18](https://www.globalkeysolutions.net/records/fda_inspections/cardinal-health-dba-specialty-pharmaceutical-services/88f7103b-ada2-41d9-95ac-14e581fe0925)
- [FDA Inspection 720529 - 2011-04-12](https://www.globalkeysolutions.net/records/fda_inspections/cardinal-health-dba-specialty-pharmaceutical-services/d8f0d524-7b71-4654-a64f-3a9501efbc23)
- [FDA Inspection 707820 - 2011-01-18](https://www.globalkeysolutions.net/records/fda_inspections/cardinal-health-dba-specialty-pharmaceutical-services/79a4ac9e-7337-4132-8840-a57d99760ced)

Company: https://www.globalkeysolutions.net/companies/cardinal-health-dba-specialty-pharmaceutical-services/926d80bc-42e1-41c6-b8d2-b7626c2678dc

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
